The Laboratory Robotics Interest Group
February 1998 Meeting
Drug Discovery
Date: Wednesday, February 25, 1998
Place: Somerset Marriot Hotel, 110 Davidson
Avenue, Somerset, NJ 08873
Phone: 732-560-0500 Fax: 732-560-3669
Itinerary: Social Period with hors doeuvres and Vendor Exhibition, 4:30
to 6:30 pm
Presentations,
6:30 to 9:00 pm
Pre-Registration: not required
Agenda: This meeting will address
the topics of Combinatorial Chemistry, Compound Distribution and Ultra High Throughput
Screening. During the Social Period which will feature hors doeuvres
and a cash bar, there will be a Vendor's Exhibition. Following will be four
presentations, with question and answer periods. Members interested in presenting a
poster during the Social Period are encouraged to do so. Open career positions at
your company may be announced or posted. There is no fee to attend the meeting.
Presentation: Massively Parallel, Microfabricated Systems for
High-Throughput Drug Discovery
Sheila H. DeWitt
Orchid Biocomputer
201 Washington Road, Princeton, NJ 08543-2197
A microfluidic, chip-based system for the integration of high-throughput drug discovery
efforts has been developed and demonstrated as a collaborative effort between SmithKline
Beecham and Orchid Biocomputer. The applications include all areas of preclinical drug
discovery including combinatorial chemistry, ultra high-throughput screening, genomics,
drug metabolism, and toxicology. The microfluidic chip incorporates microfabricated
components for valving and pumping of fluids, within a three-dimensional fluidic network.
The pumping and valving mechanisms have no moving parts, making large scale integration
feasible and inherently reliable. Key aspects of the highly integrated electrokinetic
transport of fluids, and representative examples including the transport of organic
solvents and reagents will be presented.
Presentation: UHTS: The New Challenge of the Sample Dispensary
Eric W. Kaldy
The Automation Partnership
9 Blueberry Hill Reserve, Killingworth, CT 06419
In the past few years there has been an explosion of new chemical entity generation and
biological target identification. This push coupled with the pull of the business need to
fill the product pipeline faster has created a new technology, Ultra High Throughput
Screening (UHTS). The realization of UHTS throughputs 100,000 or more assays per day
places new demands on the compound dispensary. How do you store & retrieve, prepare,
and dispatch libraries of 50,000 - 2,000,000 compounds for UHTS, HTS, and therapeutic
biology assay testing while maintaining sample and data integrity? How do you achieve both
high throughput and flexibility? This talk identifies the critical issues associated with
dispensary management and automation logistics.
Presentation: MOBA: An Ultra-High Throughput Screening Platform
For Lead Generation, Characterization, and Optimization
Frank H. Michaels, Ph.D.
Research Director, The Biotechnology Laboratories at Thomas Jefferson University
Director of Research, GEM Array Biosciences.
A cell based, ultra-high throughput screening platform technology capable of
operating in a completely automated micro-miniaturized environment is being developed.
This technology employs Genetically Engineered Microorganisms (GEMs) designed to detect
biochemical interactions of pharmacological importance. Because the screening system
employs whole viable cells, toxic compounds are detected and deleted from future
development. Additionally, because intracellular availability of lead compounds is
required for assay activity, poorly absorbed compounds are identified. Assay cycle times
are less than 2 hours, and micro- to nanomolar ED50s can be detected. New assay
development commonly requires less than 8 weeks, and subsequent lead optimization entails
significantly less time. This novel technology can detect protein-protein, RNA-protein and
DNA-protein interactions allowing the generation of arrays of microminiaturized assays to
define medically important candidates from combinatorial libraries or assemblies of crude
extracts for lead identification and optimization.
Presentation: HTS-Factory ?: An Industrial Approach to High
Throughput Screening
Ernst Burgisser
Discovery Technologies, Inc.
Switzerland
The enormous demand for rapid and cost-effective performance of high throughput screening
(HTS) is calling for novel concepts in automation and logistics. Discovery Technologies
Ltd., a newly founded service and technology company, provides custom-oriented HTS and
follow-up services. An HTS-Factory?has been designed to process up to 100,000 tests
(which is equivalent to 1,200 96-well microplates) within one working day. Higher density
formats can be implemented, as long as they fit the standard microplate footprint,
yielding a multiplication of throughput. In contrast to well-established laboratory
automation solutions, the HTS-Factory concept is based on industrial handling technology ,
which has proven to be very reliable, fast and cost-effective for more than two decades.
The key elements of the HTS-Factory are: 1.) fully automated storage and retrieval system
for chemical libraries, pre-plated in 96-well microplates and kept under dry and inert
atmosphere; 2.) all the microplate handling is done in stacks of ten plates; 3.) a newly
designed plate stacker is capable of presenting all plates within less than a minute to
liquid handlers, incubators, and readers; 4.) several 96-channel pipetters are working
simultaneously; 5.) the plates stacks are transported on a fast conveyor system with
individual shuttles; 6.) all plates are bar-coded, allowing perfect tracking and quality
assurance. Further to the high throughput mode, the system prepares assay plates for
upcoming HTS projects, compound mixture plates ("matrix cocktail"), plates for
verification assays as well as preparation of microplates for EC-50 determination in a
fully automated and unattended 24-hour mode.
Exhibiting Vendors
Argonaut Technologies |
Matrix Technologies Corp. |
Beckman Instruments Inc. |
Nalge Nunc International |
Bohdan Automation |
Nichiryo America Inc. |
Comgenex |
Perkin-Elmer Tropix |
Corning Inc. |
PerSeptive Biosystems |
Cutting Edge Scientific |
Quark Enterprises Inc. |
CRS Robotics Corporation |
Robbins Scientific |
EG&G Wallac Inc. |
Society for Biomolecular Screening |
Fisher Scientific |
The Automation Partnership |
Greiner America Inc. |
TiterTek / LabRepCo |
Hewlett Packard |
TomTec Inc. |
LJL Biosystems |
|
For more information contact:
Directions:
From Route 287 Traveling North: From Route 287 Northbound, take exit 10 (Route
527/New Brunswick/South Bound Brook). Follow Route 527 North to the first traffic
light and make a left (Davidson Avenue). Hotel is 2nd building on the left, second
driveway entrance. Hotel is adjacent to Garden State Exhibit Center.
From Route 287 Traveling South: From Route 287 Southbound, take exit 10
(Route 527/Easton Avenue/New Brunswick). At the bottom of the exit ramp get
immediately into the left lane and make a left hand turn. (Go under the underpass of
Route 287). Once you have turned left, go straight (bearing to your right - 527
North) to the first traffic light and make a left onto Davidson Avenue. Hotel is 2nd
building on the left, second driveway entrance. Hotel is adjacent to Garden State
Exhibit Center.
From New Jersey Turnpike: Take Exit 10 to Route 287 North. Follow
directions from Route 287 North.
From Garden State Parkway Traveling North: Take Exit 127 to Route 287
North. Follow directions from Route 287 North.
From Garden State Parkway Traveling South: Take Exit 129 to Route 287
North. Follow directions from Route 287 North.
From Newark Airport: Take the New Jersey Turnpike South to Exit 10 to
Route 287 North. Follow directions from Route 287 North.
From J.F.K. Airport and the Brooklyn Area: Take the Belt Parkway to the
Verrazano Narrows Bridge. Over the bridge take the Staten Island Expressway (Outer
Bridge Crossing) to Route 440 West. Follow 440 West to Route 287 North. Follow
directions from Route 287 North.
From LaGuardia Airport: Take the Grand Central Parkway to the
Brooklyn-Queens Expressway. Follow to the Verrazano Narrows Bridge. Over the
bridge take the Staten Island Expressway (Outer Bridge Crossing) to Route 440 West.
Follow 440 West to Route 287 North. Follow directions from Route 287 North.
From Philadelphia: Take the New Jersey Turnpike North to Exit 10 to
Route 287 North. Follow directions from Route 287 North.
From Mid-town Manhattan: Take either the Holland or Lincoln Tunnel to
the New Jersey Turnpike (95) South. Take Exit 10 to Route 287 North. Follow
directions from Route 287 North.
From Upstate New York/New England: Take the New York Thru-way to the
Garden State Parkway. Go South to Exit 129 to Route 287 North. Follow
directions from Route 287 North.
From Princeton Area: Take Route 202-206 North to Route 22 East to Route
287 South. Follow directions from Route 287 South. - or -
Route 1 North to 287 North. Follow directions from Route 287 North.
Sponsors: We are extremely grateful to Corning Inc.,
Hewlett Packard, and Perkin-Elmer Tropix for sponsoring this meeting and contributing
towards the hors doeuvres and mailing costs.
Long acknowledged for our expertise
in surface chemistry and materials science in polymers and glass, Corning Costar continues to advance innovative
solutions for todays emerging life science trends. We are the industry leader in
plastic vessels for cell culture and liquid handling. We are also developing leading-edge
products for the field of molecular biology. You can continue to look to Corning Costar
for the highest standards in product design and plastics molding, as well as expanding our
technology to include encapsulation of membranes into plastic devices. Weve enhanced
our offering of products and their packaging to be robotics-and automation-friendly, and
are furthering our efforts to produce environmentally sensitive materials.
Hewlett-Packard is
pleased to sponsor this meeting of the Laboratory Robotics Interest Group. Since 1965, HP
technology has given the scientific community advances in chemical analysis, such as the
electronic-recording integrator, the microprocessor-controlled analytical instrument, the
C-terminal protein sequencer, capillary electrochromatography, the digital benchtop gas
chromatograph/mass spectrometer and the fused-silica capillary column.
HP understands the benefits that automation can provide and is committed to helping
chemists in all fields of scientific endeavor become more productive. We are a pioneer in
automation, having introduced the first GC autoinjector in 1969. That same innovative
spirit continues today with autosamplers for GC and LC, automated systems for
combinatorial chemistry analysis, and the HP 7686 Solution-Phase Synthesizer.
The HP 7686 Solution-Phase Synthesizer automates organic synthesis and cleanup for lead
optimization. It can create hundreds of analogs a week in quantities sufficient to meet
screening, characterization, and archiving needs. Using the HP synthesizer, medicinal
chemists can spend their time investigating more complex or novel chemistries.
For more information about Hewlett-Packard products and services, visit us on the World
Wide Web at http://www.hp.com/go/chem.
Tropix is a leader in the development manufacture
and sale of products and services based on luminescent technology. Tropix continues to
advance luminescence technology with ongoing developments to the chemistry and
instrumentation. To date, Tropix has over 200 patents and patent applications and is
referenced in hundreds of published papers. With the TR717 microplate luminometer, Tropix
advances a complete luminescent solution for highly sensitive detection of bio-analytes.
The TR717 can detect zeptomole concentrations of analytes, can be used with 96 or 384 well
plates, and is available in a fully robotics compatible version. Tropix has recently
expanded it product offering to include the establishment of an assay development service
focused on the creation of superior performing assays specifically formatted for high
throughput screening. Tropix products and services are further strengthened by parent
company Perkin-Elmer and its Applied Biosystems division, the leader in life science
systems and instrumentation.
Group Update: The LRIG in partnership with the
Society for Biomolecular Screening (SBS) has created a working group to specify a common
set of software modules for bi-directional communication with High Throughput Screening
instruments. The overall goals are:
1) Create a common software module or modules to acquire data output from instruments into
Oracle databases (possibly set some standards).
2) Create a standard API and a common software module or modules for instrument control.
There is good representation of automation providers and integrators in the group.
We would like to have more representation for instrument (readers, etc.) manufacturers and
end users. For more information on how to participate please contact LRIG Secretary Andy Zaayenga.
visitors to this page since January 26, 1998
Back to The Laboratory Robotics Interest Group
homepage at https://www.lab-robotics.org